Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

SABSSABS
6 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in SAB BIOTHERAPEUTICS INC

RA CAPITAL MANAGEMENT, L.P. holds 4.4M shares of SABS (SAB BIOTHERAPEUTICS INC), worth $17.2M as of 2026-Q2. SABS represents 0.1% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$17.2M

Current Shares

4.4M

Total Value Change

+$15.5M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
4.4M
0.0%
$17.2M0.1%$3.90
0
2026-Q1
Unchanged
4.4M
0.0%
$16.9M0.2%$3.89
0
2025-Q4
Unchanged
4.4M
0.0%
$16.5M0.2%$3.77
0
2025-Q3
New
4.4M
-
$8.8M0.1%$1.95
46
2024-Q1
Exited
0
-100.0%
$00.0%$4.54
0
2023-Q4
New
2.4M
-
$1.6M0.0%$6.88
35

Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., BALYASNY ASSET MANAGEMENT L.P., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used